These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 30682900

  • 1. Early-stage predictors for treatment responses in patients with active lupus nephritis.
    Liu G, Wang H, Le J, Lan L, Xu Y, Yang Y, Chen J, Han F.
    Lupus; 2019 Mar; 28(3):283-289. PubMed ID: 30682900
    [Abstract] [Full Text] [Related]

  • 2. Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis.
    Kwon OC, Park Y, Lee JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S.
    Clin Rheumatol; 2019 Jan; 38(1):235-241. PubMed ID: 30094751
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.
    Sigdel MR, Kafle MP, Shah DS.
    BMC Nephrol; 2016 Oct 07; 17(1):145. PubMed ID: 27717323
    [Abstract] [Full Text] [Related]

  • 5. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 07; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 6. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
    Gururani S, Devarasetti PK, Uppin M, Rajasekhar L.
    Lupus; 2021 Oct 07; 30(11):1725-1731. PubMed ID: 34304627
    [Abstract] [Full Text] [Related]

  • 7. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
    Davies RJ, Sangle SR, Jordan NP, Aslam L, Lewis MJ, Wedgwood R, D'Cruz DP.
    Lupus; 2013 May 07; 22(6):574-82. PubMed ID: 23632989
    [Abstract] [Full Text] [Related]

  • 8. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
    Satirapoj B, Kitiyakara C, Leelahavanichkul A, Avihingsanon Y, Supasyndh O.
    BMC Nephrol; 2017 Aug 04; 18(1):263. PubMed ID: 28778196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network.
    Izmirly PM, Kim MY, Carlucci PM, Preisinger K, Cohen BZ, Deonaraine K, Zaminski D, Dall'Era M, Kalunian K, Fava A, Belmont HM, Wu M, Putterman C, Anolik J, Barnas JL, Diamond B, Davidson A, Wofsy D, Kamen D, James JA, Guthridge JM, Apruzzese W, Rao DA, Weisman MH, Accelerating Medicines Partnership in RA/SLE Network, Petri M, Buyon J, Furie R.
    Arthritis Res Ther; 2024 Feb 20; 26(1):54. PubMed ID: 38378664
    [Abstract] [Full Text] [Related]

  • 13. Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine.
    Wang S, Wang F, Wang X, Zhang Y, Song L.
    Int J Med Sci; 2021 Feb 20; 18(6):1449-1455. PubMed ID: 33628102
    [Abstract] [Full Text] [Related]

  • 14. Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis.
    Parodis I, Adamichou C, Aydin S, Gomez A, Demoulin N, Weinmann-Menke J, Houssiau FA, Tamirou F.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3424-3434. PubMed ID: 32353879
    [Abstract] [Full Text] [Related]

  • 15. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
    Navarro D, Ferreira AC, Viana H, Carvalho F, Nolasco F.
    Acta Med Port; 2019 Oct 01; 32(10):635-640. PubMed ID: 31625875
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
    Vandepapelière J, Aydin S, Cosyns JP, Depresseux G, Jadoul M, Houssiau FA.
    Lupus; 2014 Feb 01; 23(2):159-65. PubMed ID: 24300780
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis.
    Won J, Lee JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S.
    Lupus; 2019 Oct 01; 28(11):1294-1301. PubMed ID: 31583978
    [Abstract] [Full Text] [Related]

  • 20. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.
    Chan TM, Li FK, Wong RW, Wong KL, Chan KW, Cheng IK.
    Nephron; 1995 Oct 01; 71(3):321-7. PubMed ID: 8569982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.